Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

van der Heijde, Nicky ; Vissers, Frederique L ; Manzoni, Alberto ; Zimmitti, Giuseppe ; Balsells, Joaquim ; Berrevoet, Frederik ; Bjornsson, Bergthor ; van den Boezem, Peter ; Boggi, Ugo and Bratlie, Svein O , et al. (2023) In HPB 25(4). p.400-408
Abstract

BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.

METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.

RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and... (More)

BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.

METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.

RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.

CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
contributor
LU
author collaboration
publishing date
type
Contribution to journal
publication status
published
keywords
Humans, Pancreatic Neoplasms/surgery, Robotic Surgical Procedures/adverse effects, Pancreas/surgery, Pancreatectomy/adverse effects, Pancreaticoduodenectomy/adverse effects, Minimally Invasive Surgical Procedures, Laparoscopy/adverse effects, Registries, Postoperative Complications/etiology, Treatment Outcome
in
HPB
volume
25
issue
4
pages
400 - 408
publisher
Elsevier
external identifiers
  • scopus:85151563636
  • pmid:37028826
ISSN
1477-2574
DOI
10.1016/j.hpb.2022.07.015
language
English
LU publication?
no
additional info
Copyright © 2022. Published by Elsevier Ltd.
id
db024ad9-e675-42c5-bb54-bd7614d7ad07
date added to LUP
2024-09-30 13:06:03
date last changed
2024-10-01 11:50:47
@article{db024ad9-e675-42c5-bb54-bd7614d7ad07,
  abstract     = {{<p>BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.</p><p>METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.</p><p>RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.</p><p>CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.</p>}},
  author       = {{van der Heijde, Nicky and Vissers, Frederique L and Manzoni, Alberto and Zimmitti, Giuseppe and Balsells, Joaquim and Berrevoet, Frederik and Bjornsson, Bergthor and van den Boezem, Peter and Boggi, Ugo and Bratlie, Svein O and Burdio, Fernando and Coratti, Andrea and D'Hondt, Mathieu and Del Pozo, Carlos D and Dokmak, Safi and Fara, Regis and Can, Mehmet F and Festen, Sebastiaan and Forgione, Antonello and Fristrup, Claus and Gaujoux, Sebastien and Groot Koerkamp, Bas and Hackert, Thilo and Khatkov, Igor E and Keck, Tobias and Seppänen, Hanna and Lips, Daan and Luyer, Misha and Pittau, Gabriella and Maglione, Manuel and Molenaar, I Quintus and Pessaux, Patrick and Roeyen, Geert and Saint-Marc, Olivier and Cabus, Santiago S and van Santvoort, Hjalmar and van der Schelling, George and Serradilla-Martin, Mario and Souche, Francois-Regis and Suarez Muñoz, Miguel Á and Marino, Marco V and Besselink, Marc G and Abu Hilal, Mohammed}},
  issn         = {{1477-2574}},
  keywords     = {{Humans; Pancreatic Neoplasms/surgery; Robotic Surgical Procedures/adverse effects; Pancreas/surgery; Pancreatectomy/adverse effects; Pancreaticoduodenectomy/adverse effects; Minimally Invasive Surgical Procedures; Laparoscopy/adverse effects; Registries; Postoperative Complications/etiology; Treatment Outcome}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{400--408}},
  publisher    = {{Elsevier}},
  series       = {{HPB}},
  title        = {{Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry}},
  url          = {{http://dx.doi.org/10.1016/j.hpb.2022.07.015}},
  doi          = {{10.1016/j.hpb.2022.07.015}},
  volume       = {{25}},
  year         = {{2023}},
}